|1.||Tso, Patrick: 12 articles (10/2014 - 01/2003)|
|2.||Liu, Min: 10 articles (10/2014 - 04/2004)|
|3.||Woods, Stephen C: 7 articles (10/2014 - 07/2004)|
|4.||Kronenberg, Florian: 7 articles (04/2007 - 02/2002)|
|5.||Shen, Ling: 6 articles (10/2014 - 07/2004)|
|6.||Lingenhel, Arno: 6 articles (04/2009 - 05/2003)|
|7.||Kronenberg, F: 5 articles (10/2015 - 09/2000)|
|8.||Davidson, W Sean: 5 articles (04/2015 - 07/2004)|
|9.||Dieplinger, Hans: 5 articles (04/2009 - 05/2003)|
|10.||Lhotta, Karl: 4 articles (09/2006 - 02/2002)|
08/16/1996 - "Protection against atherogenesis in mice mediated by human apolipoprotein A-IV."
08/01/2006 - "The aim of the present study was to evaluate the association of apolipoprotein A-IV (APOA4) polymorphisms with coronary artery calcification (CAC) progression, a marker of subclinical atherosclerosis. "
01/01/1990 - "The baboon has been shown to be a suitable animal model for the study of atherosclerosis, and the existence of a common, multi-allele apolipoprotein A-IV polymorphism in the baboon may be useful in elucidating the role of apolipoprotein A-IV in lipid metabolism."
03/17/2003 - "The understanding of the involved mechanisms that underline apo A-IV regulation may in the long run allow us to switch on its gene, which may confer multiple beneficial effects, including the protection from atherosclerosis."
06/01/2010 - "On logistic analysis, patients with high apo A-IV levels had a lower odds ratio for atherosclerosis (maximum CIMT > 1.0) and cardiovascular disease compared to patients with low apo A-IV levels. "
11/01/2000 - "The present study was designed to evaluate whether the apo A-IV 360His polymorphism could explain, at least in part, the interindividual variability observed during postprandial lipemia. "
01/01/1988 - "[Serum apo A-IV concentration in patients with hyperlipidemia]."
03/01/1995 - "By contrast, genetically induced hypercholesterolemia (Watanabe heritable hyperlipidemia, WHHL mutation) caused a significantly reduced level of apo A-IV (3.8 +/- 1.14 mg/dl, n = 7). "
02/01/1995 - "[Apolipoprotein A-IV and transportation of cholesterol from smooth muscle cells in experimental hyperlipidemia]."
11/01/2000 - "Data of postprandial lipemia revealed that subjects with the apo A-IV 360His allele had significantly greater postprandial levels in small triacylglycerol rich lipoproteins (TRL)-C (P<0.02), small TRL-TG (P<0.01) and large TRL-TG (P<0.05) than apo A-IV 360Gln/Gln subjects. "
05/05/2005 - "Association of the apolipoprotein A-IV: 360 Gln/His polymorphism with cerebrovascular disease, obesity, and depression in a Brazilian elderly population."
12/30/2004 - "Chronic ingestion of high fat blunts the hypothalamic apo A-IV response to lipid feeding and may therefore explain why chronic intake of high fat predisposes animals and humans to obesity."
12/30/2004 - "Apolipoprotein A-IV, food intake, and obesity."
08/01/2004 - "This raises the possibility that dysregulation of hypothalamic apo A-IV could contribute to diet-induced obesity."
08/01/2004 - "Obesity induced by a high-fat diet downregulates apolipoprotein A-IV gene expression in rat hypothalamus."
|4.||Body Weight (Weight, Body)
12/30/2004 - "Evidence also suggests apo A-IV's involvement in the long-term regulation of food intake and body weight. "
07/01/2004 - "These results indicate that the diurnal expression of hypothalamic apo A-IV is regulated by factors other than the circulating CORT, for example, the reduced food intake and body weight in adrenalectomized animals. "
06/01/2004 - "Additionally, information regarding the general involvement of apo A-IV in the regulation of food intake and body weight is stated. "
01/01/2003 - "Other evidence suggests that apo-A IV may also be involved in the long-term regulation of food intake and body weight. "
01/01/2001 - "Other evidence suggests that apo A-IV may also be involved in the long-term regulation of food intake and body weight. "
|5.||Liver Cirrhosis (Hepatic Cirrhosis)
|4.||Apolipoproteins E (ApoE)
|6.||Apolipoprotein A-I (Apolipoprotein A1)
|7.||apolipoprotein A-IV (apolipoprotein AIV)
|8.||Messenger RNA (mRNA)
|1.||Renal Dialysis (Hemodialysis)
|4.||Hormone Replacement Therapy (Therapy, Hormone Replacement)
|5.||Fat-Restricted Diet (Diet, Fat Restricted)